SLAS Discovery

Papers
(The H4-Index of SLAS Discovery is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening73
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models64
In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors46
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei42
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay40
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature37
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery35
Ex vivo discovery of synergistic drug combinations for hematologic malignancies33
A Quantitative Bioassay to Determine the Inhibitory Potency of NGF–TrkA Antagonists29
Bioassay protocol metadata annotation: Proposed standards adoption28
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies27
Protocol for 3D screening of lung cancer spheroids using natural products26
Outline and background for the EU-OS solubility prediction challenge26
An efficient and scalable data analysis solution for automated electrophysiology platforms25
Emerging drug discovery ecosystems25
A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-1924
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling24
Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease23
Automation of Organoid Cultures: Current Protocols and Applications22
The Impact of Assay Design on Medicinal Chemistry: Case Studies20
Drug repurposing screen for the rare disease ataxia-telangiectasia20
0.095460891723633